Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Dec 7, 2019; 25(45): 6668-6680
Published online Dec 7, 2019. doi: 10.3748/wjg.v25.i45.6668
Table 1 Baseline characteristics of the included patients
VariablesValue
No. of patients330
Age, mean ± SD, yr54.9 ± 12.7
Male sex, n (%)203 (61.5)
Etiology, n (%)
Viral229 (69.4)
Alcohol21 (6.4)
Autoimmune34 (10.3)
Other46 (13.9)
Laboratory tests, median (IQR)
White blood cells (109/L)5.4 (3.6-7.8)
Hemoglobin (g/L)80 (66-95)
Platelets (109/L)77 (51-115)
INR1.2 (1.1-1.4)
Total bilirubin (µmol/L)22.6 (16.1-34.8)
ALT (IU/L)23 (15-38)
AST (IU/L)35 (25-56)
Albumin (g/L)31.8 (28.4-35.3)
BUN (mmol/L)8.7 (6.1-12.4)
Creatinine (µmol/L)62.2 (48.5-77.2)
Sodium (mmol/L)138.0 (134.9-140.3)
Vital signs, median (IQR)
SBP (mmHg)110 (98-120)
DBP (mmHg)65 (57-72)
Heart rate (beats/min)88 (76-101)
Location of variceal bleeding, n (%)
Esophageal varices295 (89.4)
Gastric varices35 (10.6)
Grading of esophageal varices
Mild/ moderate/severe, n (%)2 (0.7)/44 (14.9)/249 (84.4)
Types of gastric varices
GOV2/IGV1, n (%)22 (62.9)/13 (37.1)
Ascites, n (%)233 (70.6)
Hepatic encephalopathy, n (%)28 (8.5)
Hepatocellular carcinoma, n (%)73 (22.1)
Bacterial infection, n (%)63 (19.1)
Portal vein thrombosis, n (%)97 (29.4)
Hospital intervention, n (%)
Endoscopic therapy141 (42.7)
TIPSS21 (6.4)
Surgery21 (6.4)
Charlson comorbidity index > 6, n (%)45 (13.6)
Hospital stay (d), median (IQR)13 (9-20)
Scoring system, median (IQR)
CTP7 (6-9)
CTP grade A/B/C, n (%)101 (30.6)/187 (56.7)/42 (12.7)
MELD10 (9-13)
MELD-Na12 (10-16)
CRS2 (1-3)
GBS12 (9-14)
mGBS9 (7-11)
AIMS651 (0-1)
CANUKA10 (8-12)